Cargando…

Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)

Tumor-associated antigens (TAAs) recognized by cellular and/or humoral effectors of the immune system are attractive targets for diagnostic and therapeutic approaches to human cancer. Different approaches can be used to comprehensively characterize and validate the identified TAA/anti-TAA systems, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Liping, Lei, Ningjing, Liu, Mei, Zhang, Jian-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665485/ https://www.ncbi.nlm.nih.gov/pubmed/23687996 http://dx.doi.org/10.1186/2162-3619-2-15

Ejemplares similares

Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma
por: Yang, Qian, et al.
Publicado: (2023)

Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma
por: SHAO, QING, et al.
Publicado: (2012)

Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma
por: Ma, Yangcheng, et al.
Publicado: (2022)

Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer
por: Li, Jitian, et al.
Publicado: (2016)

Autoantibody to GNAS in Early Detection of Hepatocellular Carcinoma: A Large-Scale Sample Study Combined with Verification in Serial Sera from HCC Patients
por: Wang, Xiao, et al.
Publicado: (2022)

Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver Genes
por: Wang, Keyan, et al.
Publicado: (2020)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

Tumor-associated antigen CAPERα and microvessel density in hepatocellular carcinoma
por: Dai, Liping, et al.
Publicado: (2016)

Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment
por: Xing, Mengtao, et al.
Publicado: (2021)

Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma
por: Wang, Ting, et al.
Publicado: (2017)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody‐antigen system
por: Wu, Jinyu, et al.
Publicado: (2021)

Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma
por: REN, PENGFEI, et al.
Publicado: (2013)

Autoantibodies to Tumor-Associated Antigens in Breast Carcinoma
por: Piura, Ettie, et al.
Publicado: (2010)

Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma
por: Wang, Huimin, et al.
Publicado: (2021)

dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers
por: Chu, Yen-Wei, et al.
Publicado: (2020)

Autoantibodies to Tumor-Associated Antigens in Epithelial Ovarian Carcinoma
por: Piura, Benjamin, et al.
Publicado: (2009)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023)

Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma
por: Sun, Guiying, et al.
Publicado: (2019)

MRI in detection of hepatocellular carcinoma (HCC)
por: Digumarthy, Subba R, et al.
Publicado: (2005)

Emerging Therapies for Hepatocellular Carcinoma (HCC)
por: Chakraborty, Eesha, et al.
Publicado: (2022)

Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
por: Bicer, Fuat, et al.
Publicado: (2023)

Autoantibodies against tumor-associated antigens in sputum as biomarkers for lung cancer
por: Li, Ning, et al.
Publicado: (2020)

Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays
por: Yang, Qian, et al.
Publicado: (2020)

Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach
por: Awan, Faryal Mehwish, et al.
Publicado: (2015)

Autoantibody Response to Murine Double Minute 2 Protein in Immunodiagnosis of Hepatocellular Carcinoma
por: Liu, Mei, et al.
Publicado: (2014)

An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC)
por: Huang, Wei, et al.
Publicado: (2023)

Autoantibodies to Tailor-Made Panels of Tumor-Associated Antigens in Breast Carcinoma
por: Piura, Ettie, et al.
Publicado: (2011)

Proteomics Approaches to Identify Tumor Antigen Directed Autoantibodies as Cancer Biomarkers
por: Imafuku, Yuji, et al.
Publicado: (2004)

Autoantibody signature in hepatocellular carcinoma using seromics
por: Zhang, Shu, et al.
Publicado: (2020)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

The role of noncoding RNAs in the tumor microenvironment of hepatocellular carcinoma: Noncoding RNAs in the tumor microenvironment of HCC
por: Yang, Qianqian, et al.
Publicado: (2023)

Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans
por: Qiu, Cuipeng, et al.
Publicado: (2023)

Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC)
por: Lee, Taehee, et al.
Publicado: (2022)

Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC)
por: Pazgan-Simon, Monika, et al.
Publicado: (2020)

NF-Y Overexpression in Liver Hepatocellular Carcinoma (HCC)
por: Bezzecchi, Eugenia, et al.
Publicado: (2020)

A Curious Case of Vanishing Hepatocellular Carcinoma (HCC)
por: Kwei-Nsoro, Robert, et al.
Publicado: (2023)

Using protein microarray to identify and evaluate autoantibodies to tumor‐associated antigens in ovarian cancer
por: Ma, Yan, et al.
Publicado: (2020)

Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of hepatocellular carcinoma (HCC)
por: Li, Mengting, et al.
Publicado: (2021)

Transcriptomic analysis links hepatocellular carcinoma (HCC) in HZE ion irradiated mice to a human HCC subtype with favorable outcomes
por: Ding, Liang-Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_um9rrotk48g7dj8htcj32hbrdj